| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.18e-04 | 37 | 12 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 5.10e-04 | 1244 | 12 | 5 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 5.63e-04 | 1271 | 12 | 5 | GO:0000987 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.06e-03 | 1459 | 12 | 5 | GO:0000977 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.54e-03 | 127 | 12 | 2 | GO:0008094 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 3.38e-03 | 147 | 12 | 2 | GO:0042826 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 5.17e-03 | 614 | 12 | 3 | GO:0140657 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 7.78e-03 | 1412 | 12 | 4 | GO:0000981 | |
| GeneOntologyMolecularFunction | chromatin binding | 8.65e-03 | 739 | 12 | 3 | GO:0003682 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.04e-02 | 262 | 12 | 2 | GO:0140097 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 1.52e-02 | 320 | 12 | 2 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.57e-02 | 326 | 12 | 2 | GO:0001217 | |
| GeneOntologyBiologicalProcess | mRNA processing | 9.06e-06 | 551 | 12 | 5 | GO:0006397 | |
| GeneOntologyBiologicalProcess | RNA processing | 9.23e-05 | 1500 | 12 | 6 | GO:0006396 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.05e-04 | 917 | 12 | 5 | GO:0016071 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.33e-04 | 489 | 12 | 4 | GO:0030900 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.47e-04 | 502 | 12 | 4 | GO:0008380 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 7.32e-04 | 1390 | 12 | 5 | GO:0045944 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 7.54e-04 | 1399 | 12 | 5 | GO:0045892 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 7.89e-04 | 1413 | 12 | 5 | GO:1902679 | |
| GeneOntologyBiologicalProcess | epithelium development | 9.43e-04 | 1469 | 12 | 5 | GO:0060429 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 9.59e-04 | 351 | 12 | 3 | GO:0048562 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.02e-03 | 358 | 12 | 3 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.02e-03 | 358 | 12 | 3 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.05e-03 | 362 | 12 | 3 | GO:0000375 | |
| GeneOntologyBiologicalProcess | brain development | 1.13e-03 | 859 | 12 | 4 | GO:0007420 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 1.43e-03 | 98 | 12 | 2 | GO:0008088 | |
| GeneOntologyBiologicalProcess | head development | 1.45e-03 | 919 | 12 | 4 | GO:0060322 | |
| GeneOntologyCellularComponent | chromatin | 7.94e-05 | 1480 | 12 | 6 | GO:0000785 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 6.59e-04 | 1377 | 12 | 5 | GO:0140513 | |
| MousePheno | lethality, complete penetrance | 2.40e-04 | 33 | 10 | 2 | MP:0011400 | |
| MousePheno | abnormal olfactory epithelium morphology | 5.11e-04 | 48 | 10 | 2 | MP:0008789 | |
| MousePheno | abnormal olfactory system morphology | 6.95e-04 | 56 | 10 | 2 | MP:0005499 | |
| MousePheno | abnormal inner ear vestibule morphology | 1.45e-03 | 81 | 10 | 2 | MP:0000034 | |
| MousePheno | abnormal distortion product otoacoustic emission | 1.59e-03 | 85 | 10 | 2 | MP:0004736 | |
| MousePheno | abnormal otoacoustic response | 1.63e-03 | 86 | 10 | 2 | MP:0006336 | |
| MousePheno | abnormal myocardium layer morphology | 2.65e-03 | 414 | 10 | 3 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 2.80e-03 | 422 | 10 | 3 | MP:0010545 | |
| MousePheno | abnormal cochlear inner hair cell morphology | 3.35e-03 | 124 | 10 | 2 | MP:0004393 | |
| MousePheno | taste/olfaction phenotype | 3.41e-03 | 125 | 10 | 2 | MP:0005394 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 4.25e-03 | 489 | 10 | 3 | MP:0010630 | |
| Domain | RRM_1 | 6.90e-06 | 208 | 12 | 4 | PF00076 | |
| Domain | RRM | 8.16e-06 | 217 | 12 | 4 | SM00360 | |
| Domain | RRM_dom | 9.74e-06 | 227 | 12 | 4 | IPR000504 | |
| Domain | RRM | 1.03e-05 | 230 | 12 | 4 | PS50102 | |
| Domain | - | 1.30e-05 | 244 | 12 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.61e-05 | 258 | 12 | 4 | IPR012677 | |
| Domain | Homeobox_CS | 6.10e-03 | 186 | 12 | 2 | IPR017970 | |
| Domain | Homeobox | 9.50e-03 | 234 | 12 | 2 | PF00046 | |
| Domain | HOMEOBOX_1 | 9.65e-03 | 236 | 12 | 2 | PS00027 | |
| Domain | HOX | 9.73e-03 | 237 | 12 | 2 | SM00389 | |
| Domain | Homeobox_dom | 9.89e-03 | 239 | 12 | 2 | IPR001356 | |
| Domain | HOMEOBOX_2 | 9.89e-03 | 239 | 12 | 2 | PS50071 | |
| Domain | - | 1.37e-02 | 283 | 12 | 2 | 1.10.10.60 | |
| Domain | Homeodomain-like | 1.85e-02 | 332 | 12 | 2 | IPR009057 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.79e-10 | 1082 | 12 | 8 | 38697112 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.29e-09 | 411 | 12 | 6 | 35182466 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 8.86e-08 | 1353 | 12 | 7 | 29467282 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.26e-07 | 807 | 12 | 6 | 22681889 | |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 7.28e-07 | 53 | 12 | 3 | 21532573 | |
| Pubmed | 9.09e-07 | 57 | 12 | 3 | 38223760 | ||
| Pubmed | 9.58e-07 | 58 | 12 | 3 | 30009671 | ||
| Pubmed | 1.12e-06 | 244 | 12 | 4 | 29884807 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.12e-06 | 605 | 12 | 5 | 28977666 | |
| Pubmed | Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC. | 1.64e-06 | 6 | 12 | 2 | 10635329 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 2.02e-06 | 283 | 12 | 4 | 28533407 | |
| Pubmed | 2.29e-06 | 7 | 12 | 2 | 15975576 | ||
| Pubmed | 2.35e-06 | 78 | 12 | 3 | 28611094 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 2.53e-06 | 714 | 12 | 5 | 28302793 | |
| Pubmed | 2.84e-06 | 731 | 12 | 5 | 29298432 | ||
| Pubmed | 4.49e-06 | 803 | 12 | 5 | 36517590 | ||
| Pubmed | Affinity purification strategies for proteomic analysis of transcription factor complexes. | 4.54e-06 | 97 | 12 | 3 | 23937658 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 4.84e-06 | 353 | 12 | 4 | 27545878 | |
| Pubmed | 5.99e-06 | 11 | 12 | 2 | 15215307 | ||
| Pubmed | 6.45e-06 | 109 | 12 | 3 | 29511296 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 6.45e-06 | 109 | 12 | 3 | 33554859 | |
| Pubmed | 7.85e-06 | 399 | 12 | 4 | 35987950 | ||
| Pubmed | 9.70e-06 | 421 | 12 | 4 | 34650049 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.04e-05 | 954 | 12 | 5 | 36373674 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 1.10e-05 | 130 | 12 | 3 | 32905556 | |
| Pubmed | 1.12e-05 | 131 | 12 | 3 | 34551306 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.55e-05 | 146 | 12 | 3 | 23892456 | |
| Pubmed | 1.66e-05 | 18 | 12 | 2 | 23359544 | ||
| Pubmed | 1.72e-05 | 151 | 12 | 3 | 18457437 | ||
| Pubmed | 1.78e-05 | 153 | 12 | 3 | 28225217 | ||
| Pubmed | 2.09e-05 | 1103 | 12 | 5 | 34189442 | ||
| Pubmed | 2.79e-05 | 551 | 12 | 4 | 34728620 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.45e-05 | 582 | 12 | 4 | 20467437 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 3.48e-05 | 583 | 12 | 4 | 29844126 | |
| Pubmed | 3.77e-05 | 1247 | 12 | 5 | 27684187 | ||
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 4.15e-05 | 203 | 12 | 3 | 24244333 | |
| Pubmed | 4.27e-05 | 205 | 12 | 3 | 28927264 | ||
| Pubmed | 4.28e-05 | 615 | 12 | 4 | 31048545 | ||
| Pubmed | 4.41e-05 | 29 | 12 | 2 | 19279220 | ||
| Pubmed | 4.41e-05 | 29 | 12 | 2 | 34175335 | ||
| Pubmed | 4.46e-05 | 208 | 12 | 3 | 11790298 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.50e-05 | 1294 | 12 | 5 | 30804502 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 4.92e-05 | 1318 | 12 | 5 | 30463901 | |
| Pubmed | 5.27e-05 | 220 | 12 | 3 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.27e-05 | 220 | 12 | 3 | 35785414 | |
| Pubmed | 5.41e-05 | 653 | 12 | 4 | 22586326 | ||
| Pubmed | 5.47e-05 | 655 | 12 | 4 | 35819319 | ||
| Pubmed | 6.08e-05 | 34 | 12 | 2 | 11101529 | ||
| Pubmed | 6.83e-05 | 36 | 12 | 2 | 24147044 | ||
| Pubmed | 6.90e-05 | 241 | 12 | 3 | 23125841 | ||
| Pubmed | 7.61e-05 | 713 | 12 | 4 | 29802200 | ||
| Pubmed | 8.03e-05 | 39 | 12 | 2 | 25859222 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 8.07e-05 | 254 | 12 | 3 | 28431233 | |
| Pubmed | 8.11e-05 | 725 | 12 | 4 | 27025967 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | 8.26e-05 | 256 | 12 | 3 | 24189400 | |
| Pubmed | 8.64e-05 | 260 | 12 | 3 | 36199071 | ||
| Pubmed | 1.01e-04 | 274 | 12 | 3 | 34244482 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.04e-04 | 774 | 12 | 4 | 15302935 | |
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 1.07e-04 | 45 | 12 | 2 | 25496916 | |
| Pubmed | 1.07e-04 | 45 | 12 | 2 | 1286667 | ||
| Pubmed | 1.10e-04 | 282 | 12 | 3 | 23667531 | ||
| Pubmed | 1.12e-04 | 46 | 12 | 2 | 20301533 | ||
| Pubmed | 1.12e-04 | 46 | 12 | 2 | 20890123 | ||
| Pubmed | 1.12e-04 | 46 | 12 | 2 | 19928837 | ||
| Pubmed | Comprehensive Proteomic Analysis of PGC7-Interacting Proteins. | 1.16e-04 | 287 | 12 | 3 | 28712289 | |
| Pubmed | 1.22e-04 | 48 | 12 | 2 | 24302573 | ||
| Pubmed | 1.40e-04 | 306 | 12 | 3 | 18973680 | ||
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 1.43e-04 | 52 | 12 | 2 | 24591637 | |
| Pubmed | 1.60e-04 | 55 | 12 | 2 | 33067418 | ||
| Pubmed | 1.75e-04 | 330 | 12 | 3 | 32529326 | ||
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 1.78e-04 | 332 | 12 | 3 | 30595499 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.85e-04 | 59 | 12 | 2 | 28813667 | |
| Pubmed | 2.01e-04 | 346 | 12 | 3 | 25324306 | ||
| Pubmed | 2.03e-04 | 347 | 12 | 3 | 16033648 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.10e-04 | 351 | 12 | 3 | 38297188 | |
| Pubmed | 2.11e-04 | 63 | 12 | 2 | 37052853 | ||
| Pubmed | 2.24e-04 | 65 | 12 | 2 | 26655900 | ||
| Pubmed | SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein. | 2.31e-04 | 66 | 12 | 2 | 36095012 | |
| Pubmed | 2.42e-04 | 963 | 12 | 4 | 28671696 | ||
| Pubmed | 2.50e-04 | 971 | 12 | 4 | 33306668 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 2.68e-04 | 989 | 12 | 4 | 36424410 | |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 2.83e-04 | 73 | 12 | 2 | 32347575 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 2.94e-04 | 394 | 12 | 3 | 27248496 | |
| Pubmed | 2.99e-04 | 396 | 12 | 3 | 26687479 | ||
| Pubmed | 2.99e-04 | 75 | 12 | 2 | 31527668 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 3.03e-04 | 398 | 12 | 3 | 35016035 | |
| Pubmed | LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair. | 3.31e-04 | 79 | 12 | 2 | 26446488 | |
| Interaction | GATA4 interactions | 5.78e-08 | 411 | 12 | 6 | int:GATA4 | |
| Interaction | MECP2 interactions | 1.06e-07 | 1287 | 12 | 8 | int:MECP2 | |
| Interaction | ERG interactions | 1.18e-07 | 223 | 12 | 5 | int:ERG | |
| Interaction | MYCN interactions | 3.92e-06 | 1373 | 12 | 7 | int:MYCN | |
| Interaction | NANOG interactions | 5.23e-06 | 481 | 12 | 5 | int:NANOG | |
| Interaction | FOXC1 interactions | 7.36e-06 | 228 | 12 | 4 | int:FOXC1 | |
| Interaction | MIR29B2 interactions | 9.01e-06 | 71 | 12 | 3 | int:MIR29B2 | |
| Interaction | NR3C1 interactions | 9.02e-06 | 974 | 12 | 6 | int:NR3C1 | |
| Interaction | MIR29B1 interactions | 9.80e-06 | 73 | 12 | 3 | int:MIR29B1 | |
| Interaction | AR interactions | 1.00e-05 | 992 | 12 | 6 | int:AR | |
| Interaction | MIR20A interactions | 1.02e-05 | 74 | 12 | 3 | int:MIR20A | |
| Interaction | MIR15A interactions | 1.06e-05 | 75 | 12 | 3 | int:MIR15A | |
| Interaction | MIR429 interactions | 1.11e-05 | 76 | 12 | 3 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 1.15e-05 | 77 | 12 | 3 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 1.15e-05 | 77 | 12 | 3 | int:MIR200A | |
| Interaction | MIR31 interactions | 1.50e-05 | 84 | 12 | 3 | int:MIR31 | |
| Interaction | MIR17 interactions | 1.55e-05 | 85 | 12 | 3 | int:MIR17 | |
| Interaction | MIR93 interactions | 1.55e-05 | 85 | 12 | 3 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 1.55e-05 | 85 | 12 | 3 | int:MIR9-1 | |
| Interaction | MIR20B interactions | 1.61e-05 | 86 | 12 | 3 | int:MIR20B | |
| Interaction | MIR141 interactions | 1.72e-05 | 88 | 12 | 3 | int:MIR141 | |
| Interaction | MIR29C interactions | 1.78e-05 | 89 | 12 | 3 | int:MIR29C | |
| Interaction | MIR221 interactions | 1.84e-05 | 90 | 12 | 3 | int:MIR221 | |
| Interaction | MIR19B2 interactions | 2.10e-05 | 94 | 12 | 3 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 2.10e-05 | 94 | 12 | 3 | int:MIRLET7F1 | |
| Interaction | MIR21 interactions | 2.30e-05 | 97 | 12 | 3 | int:MIR21 | |
| Interaction | MIR363 interactions | 2.30e-05 | 97 | 12 | 3 | int:MIR363 | |
| Interaction | MATR3 interactions | 2.34e-05 | 655 | 12 | 5 | int:MATR3 | |
| Interaction | MIR128-2 interactions | 2.45e-05 | 99 | 12 | 3 | int:MIR128-2 | |
| Interaction | MIRLET7B interactions | 2.60e-05 | 101 | 12 | 3 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 2.60e-05 | 101 | 12 | 3 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 2.60e-05 | 101 | 12 | 3 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 2.68e-05 | 102 | 12 | 3 | int:MIRLET7A3 | |
| Interaction | MIR34A interactions | 2.84e-05 | 104 | 12 | 3 | int:MIR34A | |
| Interaction | MIR19B1 interactions | 2.84e-05 | 104 | 12 | 3 | int:MIR19B1 | |
| Interaction | RUNX1 interactions | 2.93e-05 | 324 | 12 | 4 | int:RUNX1 | |
| Interaction | MIRLET7E interactions | 3.01e-05 | 106 | 12 | 3 | int:MIRLET7E | |
| Interaction | MIR34B interactions | 3.36e-05 | 110 | 12 | 3 | int:MIR34B | |
| Interaction | MIRLET7I interactions | 3.74e-05 | 114 | 12 | 3 | int:MIRLET7I | |
| Interaction | MIRLET7G interactions | 4.04e-05 | 117 | 12 | 3 | int:MIRLET7G | |
| Interaction | CHD3 interactions | 4.69e-05 | 757 | 12 | 5 | int:CHD3 | |
| Interaction | TAF15 interactions | 7.20e-05 | 408 | 12 | 4 | int:TAF15 | |
| Interaction | ELF5 interactions | 7.97e-05 | 147 | 12 | 3 | int:ELF5 | |
| Interaction | CEBPB interactions | 8.46e-05 | 1443 | 12 | 6 | int:CEBPB | |
| Interaction | EED interactions | 8.52e-05 | 1445 | 12 | 6 | int:EED | |
| Interaction | RNF43 interactions | 8.60e-05 | 427 | 12 | 4 | int:RNF43 | |
| Interaction | ZC3H18 interactions | 9.46e-05 | 877 | 12 | 5 | int:ZC3H18 | |
| Interaction | TRIM31 interactions | 1.09e-04 | 454 | 12 | 4 | int:TRIM31 | |
| Interaction | EWSR1 interactions | 1.10e-04 | 906 | 12 | 5 | int:EWSR1 | |
| Interaction | CTCF interactions | 1.16e-04 | 461 | 12 | 4 | int:CTCF | |
| Interaction | SMARCA4 interactions | 1.17e-04 | 462 | 12 | 4 | int:SMARCA4 | |
| Interaction | TWIST1 interactions | 1.23e-04 | 170 | 12 | 3 | int:TWIST1 | |
| Interaction | EGR2 interactions | 1.25e-04 | 171 | 12 | 3 | int:EGR2 | |
| Interaction | PRMT5 interactions | 1.26e-04 | 471 | 12 | 4 | int:PRMT5 | |
| Interaction | CHD4 interactions | 1.30e-04 | 938 | 12 | 5 | int:CHD4 | |
| Interaction | SMC5 interactions | 1.76e-04 | 1000 | 12 | 5 | int:SMC5 | |
| Interaction | SALL3 interactions | 1.80e-04 | 34 | 12 | 2 | int:SALL3 | |
| Interaction | ADNP interactions | 1.95e-04 | 199 | 12 | 3 | int:ADNP | |
| Interaction | MEN1 interactions | 2.01e-04 | 1029 | 12 | 5 | int:MEN1 | |
| Interaction | TP53BP1 interactions | 2.02e-04 | 533 | 12 | 4 | int:TP53BP1 | |
| Interaction | RBM39 interactions | 2.14e-04 | 1042 | 12 | 5 | int:RBM39 | |
| Interaction | SP100 interactions | 2.16e-04 | 206 | 12 | 3 | int:SP100 | |
| Interaction | RBM14 interactions | 2.33e-04 | 553 | 12 | 4 | int:RBM14 | |
| Interaction | YAP1 interactions | 2.70e-04 | 1095 | 12 | 5 | int:YAP1 | |
| Interaction | RARA interactions | 2.73e-04 | 223 | 12 | 3 | int:RARA | |
| Interaction | HDAC1 interactions | 2.85e-04 | 1108 | 12 | 5 | int:HDAC1 | |
| Interaction | CUL2 interactions | 3.00e-04 | 591 | 12 | 4 | int:CUL2 | |
| Interaction | JPT1 interactions | 3.03e-04 | 44 | 12 | 2 | int:JPT1 | |
| Interaction | PHB1 interactions | 3.03e-04 | 1123 | 12 | 5 | int:PHB1 | |
| Interaction | AKAP8L interactions | 3.39e-04 | 240 | 12 | 3 | int:AKAP8L | |
| Interaction | SIRT6 interactions | 3.79e-04 | 628 | 12 | 4 | int:SIRT6 | |
| Interaction | BRD7 interactions | 4.00e-04 | 637 | 12 | 4 | int:BRD7 | |
| Interaction | HNRNPD interactions | 4.02e-04 | 638 | 12 | 4 | int:HNRNPD | |
| Interaction | TSPYL5 interactions | 4.08e-04 | 51 | 12 | 2 | int:TSPYL5 | |
| Interaction | ZBTB20 interactions | 4.24e-04 | 52 | 12 | 2 | int:ZBTB20 | |
| Interaction | DHX9 interactions | 4.63e-04 | 662 | 12 | 4 | int:DHX9 | |
| Interaction | ZMYM2 interactions | 4.84e-04 | 271 | 12 | 3 | int:ZMYM2 | |
| Interaction | CEBPA interactions | 4.90e-04 | 1245 | 12 | 5 | int:CEBPA | |
| Interaction | CIC interactions | 4.92e-04 | 673 | 12 | 4 | int:CIC | |
| Interaction | FOXD4 interactions | 5.09e-04 | 57 | 12 | 2 | int:FOXD4 | |
| Interaction | ARID1A interactions | 5.10e-04 | 276 | 12 | 3 | int:ARID1A | |
| Interaction | SSRP1 interactions | 5.27e-04 | 685 | 12 | 4 | int:SSRP1 | |
| Interaction | RNF113A interactions | 5.47e-04 | 692 | 12 | 4 | int:RNF113A | |
| Interaction | AMD1 interactions | 5.64e-04 | 60 | 12 | 2 | int:AMD1 | |
| Interaction | METTL3 interactions | 5.72e-04 | 287 | 12 | 3 | int:METTL3 | |
| Interaction | SMARCE1 interactions | 5.72e-04 | 287 | 12 | 3 | int:SMARCE1 | |
| Interaction | MOV10 interactions | 5.92e-04 | 1297 | 12 | 5 | int:MOV10 | |
| Interaction | PARP1 interactions | 6.33e-04 | 1316 | 12 | 5 | int:PARP1 | |
| Interaction | CUL4B interactions | 6.63e-04 | 728 | 12 | 4 | int:CUL4B | |
| Interaction | VSX1 interactions | 6.83e-04 | 66 | 12 | 2 | int:VSX1 | |
| Interaction | NXF1 interactions | 7.00e-04 | 1345 | 12 | 5 | int:NXF1 | |
| Interaction | SIRT7 interactions | 7.19e-04 | 744 | 12 | 4 | int:SIRT7 | |
| Interaction | MIR138-1 interactions | 7.24e-04 | 68 | 12 | 2 | int:MIR138-1 | |
| Interaction | SNW1 interactions | 7.30e-04 | 747 | 12 | 4 | int:SNW1 | |
| Interaction | SCP2 interactions | 7.67e-04 | 70 | 12 | 2 | int:SCP2 | |
| Interaction | MIR9-3 interactions | 7.67e-04 | 70 | 12 | 2 | int:MIR9-3 | |
| Interaction | FUS interactions | 7.68e-04 | 757 | 12 | 4 | int:FUS | |
| Interaction | MIR140 interactions | 7.89e-04 | 71 | 12 | 2 | int:MIR140 | |
| Interaction | MIR122 interactions | 7.89e-04 | 71 | 12 | 2 | int:MIR122 | |
| Interaction | GLDC interactions | 7.92e-04 | 321 | 12 | 3 | int:GLDC | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q21 | 4.25e-04 | 118 | 12 | 2 | chr10q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 2.59e-03 | 294 | 12 | 2 | chr1p34 | |
| GeneFamily | RNA binding motif containing | 5.79e-06 | 213 | 11 | 4 | 725 | |
| Coexpression | ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN | 1.38e-05 | 106 | 12 | 3 | M9160 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 5.75e-05 | 171 | 12 | 3 | M2947 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 7.15e-05 | 184 | 12 | 3 | M6593 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 9.46e-05 | 32 | 12 | 2 | M1558 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 9.46e-05 | 32 | 12 | 2 | MM668 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_top-relative-expression-ranked_500 | 5.50e-05 | 401 | 12 | 4 | gudmap_developingKidney_e11.5_ureteric bud_500 | |
| CoexpressionAtlas | e10.5_MaxilArch_top-relative-expression-ranked_500 | 2.44e-04 | 226 | 12 | 3 | Facebase_ST1_e10.5_MaxilArch_500 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#4_top-relative-expression-ranked_200 | 2.49e-04 | 42 | 12 | 2 | gudmap_developingKidney_e11.5_metaneph mesench_200_k4 | |
| CoexpressionAtlas | e10.5_RathkePouch_top-relative-expression-ranked_500 | 2.84e-04 | 238 | 12 | 3 | Facebase_ST1_e10.5_RathkePouch_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#3_top-relative-expression-ranked_200 | 2.86e-04 | 45 | 12 | 2 | gudmap_developingKidney_e13.5_podocyte cells_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | 3.12e-04 | 629 | 12 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-05 | 198 | 12 | 3 | c3dd887c95587f930b7afd32385627a9fa029ca4 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.82e-05 | 199 | 12 | 3 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue | 5.28e-04 | 129 | 12 | 2 | 426dfed68ce7ccc38d02e671e722e201f9eb1ce0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.87e-04 | 136 | 12 | 2 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.87e-04 | 136 | 12 | 2 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Epitheliod-3|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 5.95e-04 | 137 | 12 | 2 | a1e34ebbeda3d5a4f14917282d44fcb4dcbf3133 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.00e-04 | 159 | 12 | 2 | 916d070d099726f22deb71966efccff00f8ea071 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.00e-04 | 159 | 12 | 2 | 6599707107083af6da092fe8984afc8fd89d2bb8 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.61e-04 | 165 | 12 | 2 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | Posterior_cortex-Macroglia-POLYDENDROCYTE|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.72e-04 | 166 | 12 | 2 | a7ac5a414e3e2ff01f1c452c0a85048b17cba0b6 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 9.03e-04 | 169 | 12 | 2 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.24e-04 | 171 | 12 | 2 | 2991096336eea87740708360e34f84a00cb2eff2 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.35e-04 | 172 | 12 | 2 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.57e-04 | 174 | 12 | 2 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.57e-04 | 174 | 12 | 2 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.57e-04 | 174 | 12 | 2 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.68e-04 | 175 | 12 | 2 | 2ce8bcf9926862e723219b4246388428d0c3fdee | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.79e-04 | 176 | 12 | 2 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-Neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-04 | 177 | 12 | 2 | d1dd778d1a52305b1ea3954f81fd5364b3d57bbe | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-04 | 177 | 12 | 2 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-03 | 178 | 12 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-03 | 180 | 12 | 2 | 43fd5c498a87bb078d101298b472656f3294686a | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.02e-03 | 180 | 12 | 2 | ed4966765a6b25456f68185cf0648c4a3a21d7fe | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.02e-03 | 180 | 12 | 2 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 1.06e-03 | 183 | 12 | 2 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-03 | 183 | 12 | 2 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | (230)_CD4+/CD25+_Reg_T_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 1.08e-03 | 185 | 12 | 2 | f846166cec84985d6a09a45d045acd686174b6d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-03 | 186 | 12 | 2 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-03 | 186 | 12 | 2 | 76535681667c8afb884fa72b6edfee9e1e46335b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | 5fae538de481367cf6d9a2d52190d77b99f6922c | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-03 | 187 | 12 | 2 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | 22fd1959879705a8c1128faa9de66696c4e0b7e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-03 | 187 | 12 | 2 | 0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.10e-03 | 187 | 12 | 2 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.10e-03 | 187 | 12 | 2 | c2940aec30b3c2c113f6a65126dc6f1969cf301e | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.12e-03 | 188 | 12 | 2 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-03 | 189 | 12 | 2 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.13e-03 | 189 | 12 | 2 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-03 | 190 | 12 | 2 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-03 | 192 | 12 | 2 | d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_follicular_helper_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-03 | 192 | 12 | 2 | 3e2a0f332e7f9833ba88f3c809cee78b65090401 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.16e-03 | 192 | 12 | 2 | 1aa5e4d9b32013a3f272561dcb8377f6805706df | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-03 | 192 | 12 | 2 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-03 | 193 | 12 | 2 | 9661ea0ee7273928c7de2a9f49e853595fa77699 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-03 | 193 | 12 | 2 | 979980369d2dbee9dc4770d72b93037abd7786eb | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-03 | 193 | 12 | 2 | cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87 | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-03 | 193 | 12 | 2 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.17e-03 | 193 | 12 | 2 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-03 | 193 | 12 | 2 | 66af80f4b51e1ce97b6fb7c630dc5f95bfa7e7d4 | |
| ToppCell | Severe-CD4+_T|World / Disease group and Cell class | 1.19e-03 | 194 | 12 | 2 | 2ad888f78765ecfb8d1ea978c75c90fa3030509a | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-03 | 194 | 12 | 2 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.19e-03 | 194 | 12 | 2 | 20f81f457ab0a404600effe8beb91fe73d1cfc10 | |
| ToppCell | Control-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.20e-03 | 195 | 12 | 2 | 8679a122fe796b1eddef82460e985b3fd3b3a2a5 | |
| ToppCell | 390C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-03 | 195 | 12 | 2 | b955e83c2bf7a7e20ee50fab9dc9678f36d5bfd6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.21e-03 | 196 | 12 | 2 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-03 | 196 | 12 | 2 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.21e-03 | 196 | 12 | 2 | eea354bdaf4c558df6a94ec4f2f817f7073821d9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 196 | 12 | 2 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 1.22e-03 | 197 | 12 | 2 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-03 | 197 | 12 | 2 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-03 | 197 | 12 | 2 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-03 | 197 | 12 | 2 | 1378bf90a4b80b8166ef352c282ce51b114ba693 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-03 | 197 | 12 | 2 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-03 | 197 | 12 | 2 | cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-03 | 198 | 12 | 2 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-03 | 198 | 12 | 2 | e442692a8a5aad5b84eabbf051d32eae01b1069a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-03 | 198 | 12 | 2 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | Control-CD4+_T|Control / Disease group and Cell class | 1.24e-03 | 198 | 12 | 2 | 2682eea9b34cfc7e82891c1f1117d3c874107af6 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-03 | 198 | 12 | 2 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | control-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.24e-03 | 198 | 12 | 2 | 14bd612e9f9358ebff6cf8dda6a3165de9e4e3b0 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.24e-03 | 198 | 12 | 2 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-03 | 198 | 12 | 2 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | Transverse-T_cell-Th1|T_cell / Region, Cell class and subclass | 1.25e-03 | 199 | 12 | 2 | 9271d9d36ffe1c169049d4340258f366916adfaf | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-03 | 199 | 12 | 2 | c3c73c9404a73133bfad1f9ced292f5e508ef767 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.25e-03 | 199 | 12 | 2 | f3cc3cda38f78d1d12d865df339d93c5fecf19f2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-03 | 199 | 12 | 2 | 47466253069d4b1b8f13ce3210f434e60753b38a | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 1.25e-03 | 199 | 12 | 2 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-03 | 199 | 12 | 2 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.25e-03 | 199 | 12 | 2 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.26e-03 | 200 | 12 | 2 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-03 | 200 | 12 | 2 | 55f19f990fa02664aa02812f6fc65f93d5e7f382 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.26e-03 | 200 | 12 | 2 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| Drug | glutamin | 2.35e-06 | 461 | 12 | 5 | CID000000738 | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.40e-06 | 194 | 12 | 4 | 4617_DN | |
| Drug | Benzydamine hydrochloride [132-69-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.65e-06 | 199 | 12 | 4 | 5811_UP | |
| Drug | indium oxide | 3.82e-06 | 6 | 12 | 2 | CID000150905 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; HL60; HG-U133A | 1.25e-04 | 193 | 12 | 3 | 1774_DN | |
| Drug | Ceforanide [60925-61-3]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.25e-04 | 193 | 12 | 3 | 6751_DN | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.25e-04 | 193 | 12 | 3 | 6646_DN | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.27e-04 | 194 | 12 | 3 | 5049_DN | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.29e-04 | 195 | 12 | 3 | 2767_UP | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.31e-04 | 196 | 12 | 3 | 5061_DN | |
| Drug | 1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.31e-04 | 196 | 12 | 3 | 2_DN | |
| Drug | PNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 6563_UP | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 1.37e-04 | 199 | 12 | 3 | 7191_DN | |
| Drug | CD437 | 1.45e-04 | 203 | 12 | 3 | CID000135411 | |
| Disease | hearing impairment | 5.89e-04 | 98 | 11 | 2 | C1384666 | |
| Disease | Carcinoma, Granular Cell | 8.23e-04 | 116 | 11 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 8.23e-04 | 116 | 11 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 8.23e-04 | 116 | 11 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 8.23e-04 | 116 | 11 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 8.23e-04 | 116 | 11 | 2 | C0205641 | |
| Disease | Adenocarcinoma | 8.23e-04 | 116 | 11 | 2 | C0001418 | |
| Disease | colorectal cancer (is_marker_for) | 1.50e-03 | 157 | 11 | 2 | DOID:9256 (is_marker_for) | |
| Disease | granulocyte percentage of myeloid white cells | 4.28e-03 | 268 | 11 | 2 | EFO_0007997 | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.09e-03 | 293 | 11 | 2 | C1708349 | |
| Disease | Stomach Neoplasms | 5.23e-03 | 297 | 11 | 2 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 5.33e-03 | 300 | 11 | 2 | C0024623 | |
| Disease | free androgen index | 8.17e-03 | 374 | 11 | 2 | EFO_0007005 | |
| Disease | neutrophil count | 1.27e-02 | 1382 | 11 | 3 | EFO_0004833 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGSGGGQMGVYPGMQ | 116 | Q9P2D1 | |
| GMFQGMRGGGAFPGG | 231 | Q9ULX6 | |
| AGMAGGINPMGAGGQ | 826 | O14497 | |
| GGMMGTGPPYGQGIN | 921 | O14497 | |
| MSSGQGPNGGMGDPY | 1246 | O14497 | |
| QAAYPGGGGGGLAGM | 161 | Q03052 | |
| PGGGSGMGGSGMGGY | 271 | P31942 | |
| GMGGSGMGGYGRDGM | 276 | P31942 | |
| YYGQGGMSGGGWRGM | 331 | P31942 | |
| QGLYPGGGGMAGQSA | 56 | P09629 | |
| YGMGGVGGLGSMYGG | 231 | Q8N4S9 | |
| TGMQGAGIQGGGMQG | 516 | Q9H0L4 | |
| YQSAGGMPGGMPGGF | 611 | P11142 | |
| NIGGVMGNLGPGGMG | 351 | Q9P2K5 | |
| MDGPGFGGMNRIGGG | 366 | Q9P2K5 | |
| RMGGGGAMNMGDPYG | 611 | P23246 | |
| GMMGVGVAGGFGAGP | 236 | Q5TEC3 |